Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases
GJM Herder,1 H Codrington,2 CD Colder,3 JG Aerts4,51St Antonius Hospital, Nieuwegein, The Netherlands; 2Haga Hospital, The Hague, The Netherlands; 3St Jansdal Hospital, Harderwijk, The Netherlands; 4Amphia Hospital, Breda; 5Erasmus MC Rotterdam, The NetherlandsIntroduction: Previous research showed...
Saved in:
Main Authors: | Herder GJM, Codrington H, Colder CD, Aerts JG |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/5b5fdb05a88e4542a6ff4adb45ba0468 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bevacizumab in the treatment of NSCLC: patient selection and perspectives
by: Russo AE, et al.
Published: (2017) -
A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival
by: Sipeng Shen, et al.
Published: (2021) -
Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC
by: Jessica S. Donington, MD
Published: (2021) -
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
by: Okimoto RA, et al.
Published: (2015) -
MET overexpression and gene amplification in NSCLC: a clinical perspective
by: Landi L, et al.
Published: (2013)